Aflibercept 8mg for neovascular age related macular degeneration refractory to faricimab

Japanese Journal of Ophthalmology · Published 2026-07-22 · DOI 10.1007/s10384-026-01407-3

Free full text

Authors (3)

Juliana H. Moribe, Misa Masaoka, Kenji Yamashiro

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Moribe, J., Masaoka, M., Yamashiro, K. (2026). Aflibercept 8mg for neovascular age related macular degeneration refractory to faricimab. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-026-01407-3

Related articles

• Corrected gestational age–specific prediction models for identifying treatment-requiring retinopathy of prematurity · Japanese Journal of Ophthalmology · 2026 · Same journal
• Ultra-widefield indocyanine green angiography findings of vortex veins in central serous chorioretinopathy · Japanese Journal of Ophthalmology · 2026 · Same journal
• Endoluminal lacrimal duct recanalization for pediatric lacrimal duct obstruction: etiologic spectrum and surgical outcomes · Japanese Journal of Ophthalmology · 2026 · Same journal
• Clinical performance of the multiplex solid-phase “Direct Strip PCR” for infectious uveitis: a multicenter diagnostic accuracy study · Japanese Journal of Ophthalmology · 2026 · Same journal
• Establishing absolute and vitreous-normalized reference apparent diffusion coefficient values of the lacrimal gland in healthy individuals · Japanese Journal of Ophthalmology · 2026 · Same journal
• Clinical characteristics of angioid streaks in Japanese patients · Japanese Journal of Ophthalmology · 2026 · Same journal
• Optic nerve head abnormalities in primary open-angle glaucoma and their associations with axial length · Japanese Journal of Ophthalmology · 2026 · Same journal
• Collaborative care for retinal artery occlusion by ophthalmologists and vascular neurologists: management of systemic complications · Japanese Journal of Ophthalmology · 2026 · Same journal
• Trends in childhood myopia over a 5-year interval: Korea national health and nutrition examination survey 2016 and 2021 · Japanese Journal of Ophthalmology · 2026 · Same journal
• Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration · Japanese Journal of Ophthalmology · 2026 · Same journal